Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump

The announcement, which Trump made with Pfizer CEO Albert Bourla at the White House, came as the Republican president has for months sought to lower drug costs. Under the agreement, New York-based Pfizer will charge most-favored-nation pricing to Medicaid and guarantee that pricing on newly launche...

Redirecting to full article...